Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Novadip Biosciences has raised $11.9M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2026.
Novadip Biosciences's investors include New Science Ventures, Vives Louvain Technology Fund, WE International, Sambrinvest, Noshaq.
Novadip Biosciences is headquartered in Mont-saint-guibert, Belgium.
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Novadip Biosciences is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novadip Biosciences — Funding & Investors." VCBacked, September 21, 2026, https://www.vcbacked.co/company/novadip-biosciences. Accessed October 7, 2026.
VCBacked. (2026). Novadip Biosciences — Funding & Investors. Retrieved October 7, 2026, from https://www.vcbacked.co/company/novadip-biosciences
{{cite web |title=Novadip Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/novadip-biosciences |website=VCBacked |access-date=October 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated